VANGUARD GROUP INC 13D and 13G filings for DexCom, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 6:02 pm Sale | 2026-03-13 | 13G | DEXCOM, INC DXCM | VANGUARD GROUP INC | 0 0.000% | -49,455,578 (Position Closed) | Filing |
| 2025-10-30 2:56 pm Purchase | 2025-09-30 | 13G | DEXCOM, INC DXCM | VANGUARD GROUP INC | 49,455,578 12.610% | 4,988,427 (+11.22%) | Filing |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | DEXCOM, INC DXCM | VANGUARD GROUP INC | 44,467,151 11.510% | 647,315 (+1.48%) | Filing |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | DEXCOM, INC DXCM | VANGUARD GROUP INC | 43,819,836 11.340% | 2,178,560 (+5.23%) | Filing |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | DEXCOM, INC DXCM | VANGUARD GROUP INC | 41,641,276 10.740% | 712,296 (+1.74%) | Filing |